WILMINGTON, Mass., Nov. 5, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA), announces that its third quarter 2012 corporate highlights and financial results press release will be issued on Thursday, November 8th at 6:30 a.m. to be followed by a conference call and audio webcast at 8:30 a.m. Conference call dial in and webcast log in details are as follows:
Thursday, November 8th - 8:30 a.m. E.S.T.
North American callers dial:
International callers dial:
Participant Conference ID: 50053241
A telephone replay will be available shortly after the live call concludes. To access the replay, dial 855-859-2056 (North American callers) or 404-537-3406 (International callers). The telephone replay and webcast will also be accessible on the investors section of our website approximately six hours following the call at www.dusapharma.com.
About DUSA Pharmaceuticals
DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform. Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% plus blue light illumination using DUSA's BLU-U® Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp.
CONTACT: For further information contact: Chad Rubin, The Trout Group LLC Tel: 646-378-2947